Detail akcie Shionogi & Co online

Business Summary: Shionogi & Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the research and development, purchasing, manufacturing, sales, and related activities of ethical pharmaceuticals. The Company is engaged in research and development, purchasing, manufacturing, and marketing of pharmaceuticals for the treatment of gram-negative bacterial infections, influenza virus infections, new coronavirus infections, invasive aspergillus infections, complicated urinary tract infections including pyelonephritis, Alzheimer's disease, chronic pain, cancer of the esophagus, bladder, head and neck, solid tumors, and other diseases. The Company provides products and services in Japan, Europe, North America, and other regions.
Financial Summary: BRIEF: For the three months ended 30 June 2025, Shionogi & Co Ltd revenues increased 2% to Y99.78B. Net income applicable to common stockholders increased 28% to Y39.36B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research&Development Expenses-SGA decrease of 15% to Y24.89B (expense), Finance income increase of 21% to Y13.56B (income).